维普期刊资源整合服务平台（V6.5）

175篇 您的检索式：作者名="Gelmon"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Ki67 in breast cancer: prognostic and predictive potential显示文摘	Rinat Yerushalmi Ryan Woods Peter M Ravdin Malcolm M Hayes Karen A Gelmon	2010	Lancet Oncology2010，，2：	4
2	Pharmacokinetics, safety, and efficacy of trastuzumsb administered every three weeks in combination with paclitaxel 显示文摘	GELMON K AYOUB J-P	2003	J Clin Oncol2003，21，：	1
3	randomized comparative study of two doses of patients with metastatie breast eancer显示文摘	Nabholtz JM Gelmon K Bontenbal M	1996	J Clin Multicenter paclitaxel in Oneol1996，14，6：	1
4	Improving quality and safety education:The QSEN Learning Collaborative显示文摘	Conenwett L Sherwood G Gelmon SB	2009	Nurs Outlook2009，57，6：	1
5	Safety, pharmacoki- netics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors 显示文摘	BATIST G GELMON KA CHI KN	2009	Clin Cancer Res2009，15，2：	1
6	Randomized phaseⅡstudy of high-dosepaclitaxel with or without amifostine in patients with metastatic breast cancer显示文摘	Gelmon K Eisenhauer E Bryce C	1999	J ClinOncol1999，17，10：	1
7	Phase Ⅰ and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks显示文摘	DAVIS AJ GELMON KA SIU LL	2003	Invest New Drugs2003，21，1：	1
8	Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy显示文摘	BASELGA J GELMON KA VERMA S	2010	J Clin Oncol2010，28，7：	1
9	The role of PARP inhibitors in the treatment of ovarian carcinomas 显示文摘	Tinker AV Gelmon K	2012	Curr Pharm Des2012，18，25：	1
10	Phas Ⅱ triai of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy显示文摘	Baselga J Gelmon KA Verma S et a/	2010	J C/in Oncol2010，28，7：	1
11	The taxoids: paclitaxel and docetaxel 显示文摘	GELMON K	1994	Lanet1994，344，：	1
12	Multi- center, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer显示文摘	Nabholtz JM Gelmon K Bontenbal M	1996	J Clin Oncol1996，14，6：	1
13	Phase II trial of pertuzumab and trastuzumabin patients with human epidermal growth factor receptor 2-pos it ivem et astatic breast cancer that progress ed duri ng prior trast uzumab therapy显示文摘	Baselga J Gelmon KA Verma S		0，，07：	1
14	Bone-targeted a- gents and skeletal-related events in breast cancer patients with- bone metastases:the state of the art显示文摘	Clemons M Gelmon KA Pritchard KI	2012	Curt Oncol2012，19，5：	1
15	Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction显示文摘	Warburton C Dragowska WH Gelmon K	2004	Clin Cancer Res2004，10，7：	1
16	Development and assessment of conven-tional and targeted drug combinations for use in the treatment of aggressive breast cancers 显示文摘	Waterhouse DN Gelmon KA Klasa R	2006	Curr Cancer Drug Targets2006，6，6：	1
17	Lapatinib for breast canc- er: a review of the current literature显示文摘	Macfarlane R J Gelmon K A	2011	Expert Opin Drug Saf2011，10，：	1
18	Paclitaxel and concurrent radiotherapy in locally advanced non small cell lung cancer: the canadian experience显示文摘	Kirkbride P Gelmon K Eisenhauer E	1999	Semin Oneol1999，9，21：	1
19	Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trascuzumab therapy 显示文摘	Baselga J Gelmon KA Vema S	2010	J clin Oncol2010，28，7：	1
20	Phase I study of liposomal vincristine 显示文摘	GELMON KA TOLCHER A DIAB AR	1999	J Clin Oncol1999，17，2：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示